604 related articles for article (PubMed ID: 27521834)
1. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
2. Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro.
Módis K; Coletta C; Asimakopoulou A; Szczesny B; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Nitric Oxide; 2014 Sep; 41():146-56. PubMed ID: 24667534
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cystathionine-β-synthase inhibition by disulfiram: The role of bis(N,N-diethyldithiocarbamate)-copper(II).
Zuhra K; Panagaki T; Randi EB; Augsburger F; Blondel M; Friocourt G; Herault Y; Szabo C
Biochem Pharmacol; 2020 Dec; 182():114267. PubMed ID: 33035509
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer.
Szabo C; Coletta C; Chao C; Módis K; Szczesny B; Papapetropoulos A; Hellmich MR
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12474-9. PubMed ID: 23836652
[TBL] [Abstract][Full Text] [Related]
5. H
Untereiner AA; Oláh G; Módis K; Hellmich MR; Szabo C
Biochem Pharmacol; 2017 Jul; 136():86-98. PubMed ID: 28404377
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition Concept.
Hellmich MR; Chao C; Módis K; Ding Y; Zatarain JR; Thanki K; Maskey M; Druzhyna N; Untereiner AA; Ahmad A; Xue Y; Chen H; Russell WK; Wang J; Zhou J; Szabo C
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439739
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance induces the upregulation of H
Untereiner AA; Pavlidou A; Druzhyna N; Papapetropoulos A; Hellmich MR; Szabo C
Biochem Pharmacol; 2018 Mar; 149():174-185. PubMed ID: 29061341
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological actions of the slow release hydrogen sulfide donor GYY4137 on phenylephrine-induced tone in isolated bovine ciliary artery.
Chitnis MK; Njie-Mbye YF; Opere CA; Wood ME; Whiteman M; Ohia SE
Exp Eye Res; 2013 Nov; 116():350-4. PubMed ID: 24145109
[TBL] [Abstract][Full Text] [Related]
9. Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach.
Chao C; Zatarain JR; Ding Y; Coletta C; Mrazek AA; Druzhyna N; Johnson P; Chen H; Hellmich JL; Asimakopoulou A; Yanagi K; Olah G; Szoleczky P; Törö G; Bohanon FJ; Cheema M; Lewis R; Eckelbarger D; Ahmad A; Módis K; Untereiner A; Szczesny B; Papapetropoulos A; Zhou J; Hellmich MR; Szabo C
Mol Med; 2016 Sep; 22():361-379. PubMed ID: 27257787
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CyR61 expression and release by 3-mercaptopyruvate sulfurtransferase in colon cancer cells.
Ascenção K; Lheimeur B; Szabo C
Redox Biol; 2022 Oct; 56():102466. PubMed ID: 36113340
[TBL] [Abstract][Full Text] [Related]
11. Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells.
Santos SS; Rodrigues LOCP; Martins V; Petrosino M; Zuhra K; Ascenção K; Anand A; Abdel-Kader RM; Gad MZ; Bourquin C; Szabo C
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978895
[TBL] [Abstract][Full Text] [Related]
12. CBS and CSE are critical for maintenance of mitochondrial function and glucocorticoid production in adrenal cortex.
Wang CN; Liu YJ; Duan GL; Zhao W; Li XH; Zhu XY; Ni X
Antioxid Redox Signal; 2014 Dec; 21(16):2192-207. PubMed ID: 24702258
[TBL] [Abstract][Full Text] [Related]
13. H
Petrosino M; Zuhra K; Kopec J; Hutchin A; Szabo C; Majtan T
Cell Mol Life Sci; 2022 Jul; 79(8):438. PubMed ID: 35864237
[TBL] [Abstract][Full Text] [Related]
14. Cystathionine β Synthase/Hydrogen Sulfide Signaling in Multiple Myeloma Regulates Cell Proliferation and Apoptosis.
Zhang M; Li J; Huang B; Kuang L; Xiao F; Zheng D
J Environ Pathol Toxicol Oncol; 2020; 39(3):281-290. PubMed ID: 32865918
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological induction of mesenchymal-epithelial transition via inhibition of H2S biosynthesis and consequent suppression of ACLY activity in colon cancer cells.
Ascenção K; Dilek N; Augsburger F; Panagaki T; Zuhra K; Szabo C
Pharmacol Res; 2021 Mar; 165():105393. PubMed ID: 33484818
[TBL] [Abstract][Full Text] [Related]
16. Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.
Oláh G; Módis K; Törö G; Hellmich MR; Szczesny B; Szabo C
Biochem Pharmacol; 2018 Mar; 149():186-204. PubMed ID: 29074106
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE).
Asimakopoulou A; Panopoulos P; Chasapis CT; Coletta C; Zhou Z; Cirino G; Giannis A; Szabo C; Spyroulias GA; Papapetropoulos A
Br J Pharmacol; 2013 Jun; 169(4):922-32. PubMed ID: 23488457
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide promotes adipogenesis in 3T3L1 cells.
Tsai CY; Peh MT; Feng W; Dymock BW; Moore PK
PLoS One; 2015; 10(3):e0119511. PubMed ID: 25822632
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: Structure-activity relationship and mechanism of action.
Zuhra K; Petrosino M; Gupta B; Panagaki T; Cecconi M; Myrianthopoulos V; Schneiter R; Mikros E; Majtan T; Szabo C
Nitric Oxide; 2022 Nov; 128():12-24. PubMed ID: 35973674
[TBL] [Abstract][Full Text] [Related]
20. Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS.
Yue T; Zuo S; Bu D; Zhu J; Chen S; Ma Y; Ma J; Guo S; Wen L; Zhang X; Hu J; Wang Y; Yao Z; Chen G; Wang X; Pan Y; Wang P; Liu Y
J Cancer; 2020; 11(7):1828-1838. PubMed ID: 32194794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
